BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24256360)

  • 1. The challenges of LC-MS/MS analysis of opiates and opioids in urine.
    French D
    Bioanalysis; 2013 Nov; 5(22):2803-20. PubMed ID: 24256360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous determination of 18 abused opioids and metabolites in human hair using LC-MS/MS and illegal opioids abuse proven by hair analysis.
    Kim J; Ji D; Kang S; Park M; Yang W; Kim E; Choi H; Lee S
    J Pharm Biomed Anal; 2014 Feb; 89():99-105. PubMed ID: 24270290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic monitoring of opioids: a sensitive LC-MS/MS method for quantitation of several opioids including hydrocodone and its metabolites.
    Langman LJ; Korman E; Stauble ME; Boswell MV; Baumgartner RN; Jortani SA
    Ther Drug Monit; 2013 Jun; 35(3):352-9. PubMed ID: 23666565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative, Multidrug Pain Medication Testing by Liquid Chromatography: Tandem Mass Spectrometry (LC-MS/MS).
    Bodor GS
    Methods Mol Biol; 2016; 1383():223-40. PubMed ID: 26660191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrophilic interaction LC-MS/MS analysis of opioids in urine: significance of glucuronide metabolites.
    French D; Wu A; Lynch K
    Bioanalysis; 2011 Dec; 3(23):2603-12. PubMed ID: 22136049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitation of Buprenorphine, Norbuprenorphine, Buprenorphine Glucuronide, Norbuprenorphine Glucuronide, and Naloxone in Urine by LC-MS/MS.
    Marin SJ; McMillin GA
    Methods Mol Biol; 2016; 1383():69-78. PubMed ID: 26660175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of opiates and cocaine in urine by high pH mobile phase reversed phase UPLC-MS/MS.
    Berg T; Lundanes E; Christophersen AS; Strand DH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(4):421-32. PubMed ID: 19144579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of opiates, methadone, buprenorphine and metabolites in human urine by superficially porous liquid chromatography tandem mass spectrometry.
    Lin HR; Chen CL; Huang CL; Chen ST; Lua AC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 925():10-5. PubMed ID: 23507455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous quantification of amphetamine, opiates, ketamine and relative metabolites in urine for confirmatory analysis by liquid chromatography tandem mass spectrometry.
    Lin HR; Choi KI; Lin TC; Hu A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jun; 929():133-41. PubMed ID: 23672816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of Total Buprenorphine and Norbuprenorphine in Meconium by LC-MS/MS.
    Marin SJ; McMillin GA
    Methods Mol Biol; 2016; 1383():59-68. PubMed ID: 26660174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved buprenorphine immunoassay performance after urine treatment with β-glucuronidase.
    Snyder ML; Darragh A; Flood JG; Jones J; Ropar K; Jarolim P; Melanson SE
    J Anal Toxicol; 2014; 38(6):375-9. PubMed ID: 24802159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthetic opioid analysis by LC-MS/MS.
    Garby DM; Cheryk LA
    Methods Mol Biol; 2012; 902():65-73. PubMed ID: 22767108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(3):259-70. PubMed ID: 21587329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of opioids in oral fluid: Importance of chromatography and mass spectral transitions in LC-MS/MS.
    Tuyay J; Coulter C; Rodrigues W; Moore C
    Drug Test Anal; 2012 Jun; 4(6):395-401. PubMed ID: 22374679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative LC-MS/MS Analysis of Opiates and Opioids in Human Urine.
    Gqamana PP; Zhang YV
    Methods Mol Biol; 2024; 2737():377-386. PubMed ID: 38036838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved detection of opioid use in chronic pain patients through monitoring of opioid glucuronides in urine.
    Dickerson JA; Laha TJ; Pagano MB; O'Donnell BR; Hoofnagle AN
    J Anal Toxicol; 2012 Oct; 36(8):541-7. PubMed ID: 22833646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous screening and quantification of 25 opioid drugs in post-mortem blood and urine by liquid chromatography-tandem mass spectrometry.
    Gergov M; Nokua P; Vuori E; Ojanperä I
    Forensic Sci Int; 2009 Apr; 186(1-3):36-43. PubMed ID: 19232849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain Management Testing by Liquid Chromatography Tandem Mass Spectrometry.
    Bodor GS
    Clin Lab Med; 2018 Sep; 38(3):455-470. PubMed ID: 30115391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and benefits of endogenous steroid analysis by LC-MS/MS.
    Couchman L; Vincent RP; Ghataore L; Moniz CF; Taylor NF
    Bioanalysis; 2011 Nov; 3(22):2549-72. PubMed ID: 22122603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.